Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome

Stopped early · Not applicable · Has a placebo group

Conditions studied: Patellofemoral Pain Syndrome

In brief

The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.

Key facts

Study ID

NCT03717532

Run by

NYU Langone Health

People needed

1

Starts

2019-02-01

Expected to finish

2019-11-01

Last updated by the study team

2020-05-28

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ASA class I-II
• Diagnosed with patellofemoral pain syndrome

You may not qualify if…

• Patients with confirmed radiographic evidence explaining knee pain
• Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
• Younger than 18 years of age or older than 65
• Any patient considered a vulnerable subject
• Patients with impaired circulation, peripheral vascular compromise, Previous revascularization of the extremity, or severe hypertension
• Patients with Sickle cell anemia or venous thromboembolism
• Patients with Sickle cell anemia or venous thromboembolism
• Patients with cancer or Lymphectomies
• Patients with increased intracranial pressure

Where it is running

• NYU Langone Health — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.